Additional information
| Active substance | Mirtazapine |
|---|---|
| Chemical name | 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine |
| Side effects | Weight gain, sedation, dry mouth, increased appetite, dizziness |
| Effects | Antidepressant, anxiolytic, sedative |
| Dosage (sports) | Not applicable |
| Dosage (medical) | 15-45 mg per day |
| Half-life | 20 to 40 hours |
| Main action | Antidepressant, enhances central noradrenergic and serotonergic activity |
| Substance class | Tetracyclic antidepressant |
| Formula | C17H19N3 |
| Storage conditions | Store at room temperature, protect from light and moisture |
| Trade name | Remeron, others |
| Blood pressure | Can cause orthostatic hypotension |
| Also known as | Remeron |
| Strength | 15mg |
| Lab Test | Not specific |
| Hepatotoxicity | Low |
| Water Retention | Minimal |
| Use in sports | None |
| Manufacturer | Intas Pharmaceuticals Ltd. |
| Packing | 10 tabs/blister |
Reviews
There are no reviews yet.